Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
About Sygnature Discovery
At Sygnature Discovery, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible.
We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment.
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. With over 29,000 employees worldwide across 23 locations in the US, UK and China, we support drug discovery through to manufacturing with fully integrated, high-quality services.
Isomorphic Labs (IsoLabs) was launched in 2021 to advance human health by building on and beyond the Nobel-winning AlphaFold system. Since then, our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed.
About AstraZeneca
At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you're our kind of person.
Are you passionate about the immune system and its potential to transform therapies? Want to work across diverse, cutting-edge drug discovery projects with Biotech and Pharma clients?
We’re looking for a Senior Scientist to join our growing, collaborative team.
About Us - Nexus BioQuest
We are a specialist preclinical immunology CRO, partnering with Biotech and Pharma to accelerate drug development. Our work spans:
At LeafyColl, we're developing new lettuce varieties with improved commercial traits using CRISPR-Cas genome editing, and I'm looking for a scientist to take real ownership of this programme.
The role covers the full pipeline: identifying candidate genes, designing editing constructs, Agrobacterium-mediated lettuce transformation, tissue culture and shoot regeneration, through to sequence-confirmed edited plants.
Our primary requirement is proven hands-on success in generating and molecularly validating genome-edited plants, ideally lettuce (Lactuca sativa).
New RNA-based NGS panel helps to detect, analyse and track high-impact AML-associated fusion events across multiple timepoints.
Oxford, UK, October 2026.
OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of the SureSeq™ myPanel Myeloid Fusion MRD Panel, the first-to-market dedicated fusion MRD next-generation sequencing (NGS) panel for acute myeloid leukaemia (AML). This panel is now available publicly for customers to purchase and implement in their own workflows.